Analyzing the CYP21A2 gene sequence plays a vital role in carrier screening and disease diagnosis, which is essential for preventing adrenal crises and reducing mortality in newborns with the salt-wasting form of CAH. The gene discussed is CYP21A2; the disease is congenital adrenal hyperplasia.